Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Watowich, is advancing a lead NNMT inhibitor candidate ( RT-002 ) toward Phase 1 first-in-human clinical trials, with IND-enabling GLP toxicology studies in minipigs currently underway
Supplementation and therapeutic administration represent the most common benign causes
We strive to treat everyone the way we would want to be treated
In adipose tissue, inhibition of NNMT suppresses de novo lipogenesis, normalizes fat content, and improves insulin sensitivity 2-3
US$ 27.56
US$ 29.30
US$ 24.56
US$ 23.58
US$ 24.23
US$ 28.04
US$ 23.85
US$ 29.18
US$ 26.35
